Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $628.10 | 27 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Choice Spine, LLC | $172.17 | 1 | $0 (2019) |
| Amgen Inc. | $81.48 | 4 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $70.92 | 4 | $0 (2020) |
| GlaxoSmithKline, LLC. | $57.26 | 3 | $0 (2019) |
| Lilly USA, LLC | $46.02 | 3 | $0 (2019) |
| PFIZER INC. | $34.30 | 2 | $0 (2019) |
| AbbVie Inc. | $23.38 | 1 | $0 (2021) |
| Genentech USA, Inc. | $20.05 | 1 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $19.45 | 1 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $18.28 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $72.07 | 4 | AbbVie Inc. ($23.38) |
| 2020 | $22.80 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($22.80) |
| 2019 | $347.86 | 10 | Choice Spine, LLC ($172.17) |
| 2018 | $122.29 | 8 | Lilly USA, LLC ($31.20) |
| 2017 | $63.08 | 4 | GlaxoSmithKline, LLC. ($21.64) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/05/2021 | Janssen Biotech, Inc. | REMICADE (Biological), STELARA, SIMPONI ARIA | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Immunology | ||||||
| 10/27/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.45 | General |
| 09/22/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/08/2021 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: IMMUNOLOGY | ||||||
| 01/29/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: RESPIRATORY | ||||||
| 10/01/2019 | GlaxoSmithKline, LLC. | ANORO (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.42 | General |
| 07/30/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: DIABETES | ||||||
| 06/11/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $25.39 | General |
| Category: Neuroscience | ||||||
| 06/04/2019 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Diabetes | ||||||
| 05/23/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/21/2019 | GlaxoSmithKline, LLC. | BEXSERO (Biological), SHINGRIX | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: VACCINES | ||||||
| 03/14/2019 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $32.50 | General |
| Category: Bone Health | ||||||
| 03/05/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $13.53 | General |
| 02/27/2019 | Choice Spine, LLC | Blackhawk (Device), Tiger Shark, Blackbird | Food and Beverage | Cash or cash equivalent | $172.17 | General |
| Category: Spinal implant | ||||||
| 12/04/2018 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Virology & Specialty Care | ||||||
| 11/20/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/31/2018 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Endocrinology | ||||||
| 10/22/2018 | Providence Medical Technology, Inc. | CAVUX Cervical Cage (Device), DTRAX Spinal System, ALLY Bone Screw | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: MEDICAL DEVICE | ||||||
| 10/18/2018 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE, BASAGLAR | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Diabetes | ||||||
| 09/13/2018 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE, BASAGLAR | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Diabetes | ||||||
| 06/21/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/12/2018 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: Endocrinology | ||||||
| 11/30/2017 | GlaxoSmithKline, LLC. | BOOSTRIX (Biological), SHINGRIX | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: VACCINES | ||||||
| 11/08/2017 | Takeda Pharmaceuticals America, Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: Central Nervous System (CNS) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,784 | 2,407 | $558,857 | $168,592 |
| 2022 | 37 | 2,524 | 3,343 | $684,923 | $223,895 |
| 2021 | 31 | 2,106 | 2,973 | $567,245 | $227,265 |
| 2020 | 45 | 3,055 | 4,112 | $544,660 | $184,180 |
All Medicare Procedures & Services
139 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 395 | 645 | $209,625 | $57,857 | 27.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 464 | 662 | $165,500 | $39,030 | 23.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 262 | 262 | $65,500 | $34,545 | 52.7% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2023 | 65 | 67 | $18,091 | $6,290 | 34.8% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 80 | 84 | $10,675 | $4,224 | 39.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 25 | 25 | $10,925 | $3,134 | 28.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 18 | 18 | $6,750 | $3,034 | 44.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 26 | 34 | $5,100 | $2,789 | 54.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 12 | 12 | $6,247 | $2,711 | 43.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 14 | 15 | $6,000 | $2,059 | 34.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 29 | 32 | $3,200 | $1,888 | 59.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 44 | 49 | $7,350 | $1,762 | 24.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 60 | 101 | $10,925 | $1,611 | 14.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 16 | 16 | $4,800 | $1,597 | 33.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $4,500 | $1,337 | 29.7% |
| 87651 | Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | Office | 2023 | 21 | 22 | $1,934 | $756.58 | 39.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 74 | 77 | $5,775 | $721.02 | 12.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 25 | 66 | $3,960 | $661.98 | 16.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 44 | 52 | $1,404 | $495.04 | 35.3% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 16 | 23 | $3,050 | $467.07 | 15.3% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 14 | 15 | $1,800 | $427.68 | 23.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $660.00 | $346.17 | 52.5% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2023 | 12 | 18 | $2,000 | $312.19 | 15.6% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2023 | 11 | 19 | $1,900 | $289.56 | 15.2% |
| G0102 | Prostate cancer screening; digital rectal examination | Office | 2023 | 17 | 17 | $656.37 | $192.43 | 29.3% |
About Dr. Michael Yoon, M.D
Dr. Michael Yoon, M.D is a Family Medicine healthcare provider based in Danvers, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1790761294.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Yoon, M.D has received a total of $628.10 in payments from pharmaceutical and medical device companies, with $72.07 received in 2021. These payments were reported across 27 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($628.10).
As a Medicare-enrolled provider, Yoon has provided services to 9,469 Medicare beneficiaries, totaling 12,835 services with total Medicare billing of $803,932. Data is available for 4 years (2020–2023), covering 139 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Danvers, MA
- Active Since 12/16/2005
- Last Updated 12/17/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1790761294
Products in Payments
- Blackhawk (Device) $172.17
- Prolia (Biological) $56.09
- TRULICITY (Drug) $46.02
- CHANTIX (Drug) $34.30
- Aimovig (Biological) $25.39
- SYNTHROID (Drug) $23.38
- SPIRIVA RESPIMAT (Drug) $22.80
- JARDIANCE (Drug) $21.67
- BOOSTRIX (Biological) $21.64
- Xofluza (Drug) $20.05
- BEXSERO (Biological) $19.71
- JANUVIA (Drug) $19.45
- ENTRESTO (Drug) $18.28
- ANORO (Drug) $15.91
- Myrbetriq (Drug) $15.57
- REMICADE (Biological) $14.96
- Trintellix (Drug) $12.95
- STIOLTO (Drug) $12.92
- CAVUX Cervical Cage (Device) $11.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Danvers
Matthew Plosker, M.d, M.D
Family Medicine — Payments: $1,242
Mark Allara, Md, MD
Family Medicine — Payments: $910.05
Meghan Tramontozzi, Md, MD
Family Medicine — Payments: $780.22
Dr. Brent Fryling, M.d, M.D
Family Medicine — Payments: $598.96
Dana Mann, M.d, M.D
Family Medicine — Payments: $157.42
Leonard Horowitz, M.d, M.D
Family Medicine — Payments: $17.12